Correlation Between Harmony Biosciences and Aerovate Therapeutics

Can any of the company-specific risk be diversified away by investing in both Harmony Biosciences and Aerovate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harmony Biosciences and Aerovate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Harmony Biosciences Holdings and Aerovate Therapeutics, you can compare the effects of market volatilities on Harmony Biosciences and Aerovate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harmony Biosciences with a short position of Aerovate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harmony Biosciences and Aerovate Therapeutics.

Diversification Opportunities for Harmony Biosciences and Aerovate Therapeutics

0.08

Correlation Coefficient

Harmony Biosciences  Aerovate Therapeutics

Significant diversification

The 3 months correlation between Harmony and Aerovate is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding Harmony Biosciences Holdings and Aerovate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aerovate Therapeutics and Harmony Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harmony Biosciences Holdings are associated (or correlated) with Aerovate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aerovate Therapeutics has no effect on the direction of Harmony Biosciences i.e., Harmony Biosciences and Aerovate Therapeutics go up and down completely randomly.

Pair Corralation between Harmony Biosciences and Aerovate Therapeutics

Given the investment horizon of 90 days Harmony Biosciences Holdings is expected to generate 1.7 times more return on investment than Aerovate Therapeutics. However, Harmony Biosciences is 1.7 times more volatile than Aerovate Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Aerovate Therapeutics is currently generating about -0.04 per unit of risk. If you would invest  3,406  in Harmony Biosciences Holdings on December 30, 2024 and sell it today you would lose (87.00) from holding Harmony Biosciences Holdings or give up 2.55% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Harmony Biosciences Holdings  vs.  Aerovate Therapeutics

Harmony Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Harmony Biosciences Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong primary indicators, Harmony Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Harmony Biosciences and Aerovate Therapeutics

The main advantage of trading using opposite Harmony Biosciences and Aerovate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harmony Biosciences position performs unexpectedly, Aerovate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aerovate Therapeutics will offset losses from the drop in Aerovate Therapeutics' long position.

The idea behind Harmony Biosciences Holdings and Aerovate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.